Compare Vanguard Tax Managed Fund FTSE Developed Markets ETF (VEA) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vanguard Tax Managed Fund FTSE Developed Markets ETF vs Vir Biotechnology Inc. Common Stock — how do they compare? Vanguard Tax Managed Fund FTSE Developed Markets ETF trades at $68.76 (market cap $323.80B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Vanguard Tax Managed Fund FTSE Developed Markets ETF is far larger — about 179.9× Vir Biotechnology Inc. Common Stock's market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, Vanguard Tax Managed Fund FTSE Developed Markets ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Vanguard Tax Managed Fund FTSE Developed Markets ETF for 132 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| VEA | VIR | |
|---|---|---|
Market Cap | $323.80B | $1.80B |
Volume | 7,840,398 | 1,782,836 |
52-Week High | $73.79 | $11.78 |
52-Week Low | $58.90 | $5.12 |
Typical Hold Time | 132 Days | 0 Days |
Sector | — | Health |
Enterprise Value | — | $1.36B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
VEA trades at $70.06 with minimal daily movement (+0.16%). The technical outlook is bearish with moving averages signaling weakness, though oscillators remain neutral. Recent news highlights VEA's competitive advantages including a low 0.03% expense ratio and higher dividend yield compared to peers. Institutional activity shows mixed signals with some firms increasing positions while others reduced exposure.
The ETF's focus on developed international markets provides stability but faces currency and geopolitical risks. Current bearish technical signals suggest near-term caution, though the fund's cost efficiency and diversification benefits support long-term international exposure. Key risks include global economic slowdowns and currency fluctuations affecting returns.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Vanguard Tax Managed Fund FTSE Developed Markets ETF
The fund employs an indexing investment approach designed to track the performance of the FTSE Developed All Cap ex US Index, a market-capitalization-weighted index that is made up of approximately 4022 common stocks of large-, mid-, and small-cap companies located in Canada and the major markets of Europe and the Pacific region. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VEA →About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →
